Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Bansback

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the ElderlyGeorg Osterhoff, Nathan N O'Hara, Jennifer D'Cruz, et al.
JAMA Network Open|December 7, 2019
Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance CoverageMark Tatangelo, George Tomlinson, J Michael Paterson, et al.
Medical Care|October 23, 2015
A Time Trade-off-derived Value Set of the EQ-5D-5L for CanadaFeng Xie, Eleanor Pullenayegum, Kathy Gaebel, et al.
BMC Musculoskeletal Disorders|February 25, 2019
An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trialNick Bansback, Logan Trenaman, Karen V MacDonald, et al.
CMAJ Open|February 3, 2023
The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysisTracey-Lea Laba, Heather C Worthington, Lucy Cheng, et al.
Pharmacoepidemiology and Drug Safety|May 20, 2026
The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based StudyMark Harrison, Sandra Blitz, Michael Law, et al.
Patient Education and Counseling|December 24, 2018
Communicating uncertainty in cancer prognosis: A review of web-based prognostic toolsMark Harrison, Paul K J Han, Borsika Rabin, et al.
The Patient|July 1, 2019
Support Tools for Preference-Sensitive Decisions in Healthcare: Where Are We? Where Do We Go? How Do We Get There?Jan Ostermann, Derek S Brown, Janine A van Til, et al.
The Annals of Pharmacotherapy|March 5, 2019
Assessment of Condition and Medication Knowledge Gaps Among Atrial Fibrillation Patients: A Systematic Review and Meta-analysisShahrzad Salmasi, Mary A De Vera, Arden Barry, et al.
The Journal of Rheumatology|May 5, 2007
Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitisNick Bansback, Andreas Maetzel, Mike Drummond, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the ElderlyGeorg Osterhoff, Nathan N O'Hara, Jennifer D'Cruz, et al.
JAMA Network Open|December 7, 2019
Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance CoverageMark Tatangelo, George Tomlinson, J Michael Paterson, et al.
Medical Care|October 23, 2015
A Time Trade-off-derived Value Set of the EQ-5D-5L for CanadaFeng Xie, Eleanor Pullenayegum, Kathy Gaebel, et al.
BMC Musculoskeletal Disorders|February 25, 2019
An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trialNick Bansback, Logan Trenaman, Karen V MacDonald, et al.
CMAJ Open|February 3, 2023
The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysisTracey-Lea Laba, Heather C Worthington, Lucy Cheng, et al.
Pharmacoepidemiology and Drug Safety|May 20, 2026
The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based StudyMark Harrison, Sandra Blitz, Michael Law, et al.
Patient Education and Counseling|December 24, 2018
Communicating uncertainty in cancer prognosis: A review of web-based prognostic toolsMark Harrison, Paul K J Han, Borsika Rabin, et al.
The Patient|July 1, 2019
Support Tools for Preference-Sensitive Decisions in Healthcare: Where Are We? Where Do We Go? How Do We Get There?Jan Ostermann, Derek S Brown, Janine A van Til, et al.
The Annals of Pharmacotherapy|March 5, 2019
Assessment of Condition and Medication Knowledge Gaps Among Atrial Fibrillation Patients: A Systematic Review and Meta-analysisShahrzad Salmasi, Mary A De Vera, Arden Barry, et al.
The Journal of Rheumatology|May 5, 2007
Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitisNick Bansback, Andreas Maetzel, Mike Drummond, et al.
Pageof 21